Canada markets closed

Avadel Pharmaceuticals plc (AVDL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
18.31+0.15 (+0.83%)
At close: 04:00PM EDT
18.99 +0.68 (+3.71%)
After hours: 07:40PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.39B
Enterprise Value 3.29B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)52.07
Price/Book (mrq)19.91
Enterprise Value/Revenue 117.58
Enterprise Value/EBITDA -22.05

Trading Information

Stock Price History

Beta (5Y Monthly) 1.63
52-Week Change 327.89%
S&P500 52-Week Change 323.10%
52 Week High 319.04
52 Week Low 39.50
50-Day Moving Average 316.06
200-Day Moving Average 313.66

Share Statistics

Avg Vol (3 month) 31.2M
Avg Vol (10 day) 3893.71k
Shares Outstanding 596.12M
Implied Shares Outstanding 6186.69M
Float 890.58M
% Held by Insiders 14.62%
% Held by Institutions 160.05%
Shares Short (Apr 15, 2024) 410.61M
Short Ratio (Apr 15, 2024) 414.32
Short % of Float (Apr 15, 2024) 411.81%
Short % of Shares Outstanding (Apr 15, 2024) 411.72%
Shares Short (prior month Mar 15, 2024) 410.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-128.00%

Management Effectiveness

Return on Assets (ttm)-57.92%
Return on Equity (ttm)-481.35%

Income Statement

Revenue (ttm)27.96M
Revenue Per Share (ttm)0.35
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -136.08M
Net Income Avi to Common (ttm)-160.28M
Diluted EPS (ttm)-2.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)105.11M
Total Cash Per Share (mrq)1.16
Total Debt (mrq)35.38M
Total Debt/Equity (mrq)40.33%
Current Ratio (mrq)3.64
Book Value Per Share (mrq)0.98

Cash Flow Statement

Operating Cash Flow (ttm)-128.51M
Levered Free Cash Flow (ttm)-77.95M